chr1-164559839-G-GGCTGATGCATTCCCAT
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_002585.4(PBX1):c.22_37dupATGCATTCCCATGCTG(p.Gly13AspfsTer53) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002585.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
PBX1-related disorder Uncertain:1
The PBX1 c.22_37dup16 variant is predicted to result in a frameshift and premature protein termination (p.Gly13Aspfs*53). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. While frameshift variants are expected to be pathogenic, there have been no reports of loss-of-function variants upstream of this variant. In addition, there is a downstream in-frame methionine at codon 16 which cannot be ruled out as an alternative start codon. Therefore, although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.